<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02482805</url>
  </required_header>
  <id_info>
    <org_study_id>SAD - Hormones</org_study_id>
    <nct_id>NCT02482805</nct_id>
  </id_info>
  <brief_title>Hormones and Social Anxiety Disorder Treatment</brief_title>
  <official_title>Effect of Hormones on Response to Exposure Therapy for Social Anxiety Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas at Austin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas at Austin</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether power posing (i.e., holding poses
      associated with dominance and power), compared to submissive posing or rest, prior to
      exposure therapy for social anxiety disorder: 1) leads to a temporary increase in
      testosterone levels and/or 2) facilitates exposure therapy outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LSAS-performance Subscale</measure>
    <time_frame>Scores at 1 week post-treatment</time_frame>
    <description>Liebowitz Social Anxiety Scale (LSAS)-Performance Subscale at pre- and 1-week post-treatment.
The Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Units of Distress Scale (SUDs)</measure>
    <time_frame>Scores at 1 week post-treatment</time_frame>
    <description>Peak (max) SUDS ratings (0 to 100 scale) during treatment exposure and 1 week post-treatment exposure.
Peak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Salivary Testosterone Levels</measure>
    <time_frame>Baseline and 20 minutes after posture manipulation</time_frame>
    <description>Saliva sample taken before posture manipulation and 20 minutes after. Outcome is the change from pre- to post-manipulation in testosterone levels.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Social Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>Power Posing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Submissive Posing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals rest (no postures) for 2 minutes prior to exposure therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
    <description>Exposure therapy for social anxiety disorder</description>
    <arm_group_label>Power Posing</arm_group_label>
    <arm_group_label>Submissive Posing</arm_group_label>
    <arm_group_label>Rest</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Outpatients between the ages of 18 to 70 years of age with a primary psychiatric
             diagnosis (designated by the patient as the most important source of current distress)
             of social anxiety disorder as defined by DSM-5 criteria, with fear of public speaking
             endorsed as a primary concern.

          -  Willingness and ability to participate in the informed consent process and comply with
             the requirements of the study protocol.

        Exclusion Criteria:

          -  Current use of testosterone enhancing products (i.e., gels, creams, or injections)

          -  A lifetime history of bipolar disorder, schizophrenia, psychosis, or delusional
             disorders; organic brain syndrome, mental retardation or other cognitive dysfunction
             that could interfere with capacity to engage in therapy; a history of substance or
             alcohol abuse or dependence (other than nicotine) in the last 6 months.

          -  Entry of patients with other mood or anxiety disorders will be permitted in order to
             increase accrual of a clinically relevant sample; however in cases where SAD is not
             judged to be the predominant disorder, participants will not be eligible.

          -  Patients with significant suicidal ideation or who have enacted suicidal behaviors
             within 6 months prior to intake will be excluded from study participation and referred
             for appropriate clinical intervention.

          -  Patients using psychotropic medication (e.g., antidepressants, anxiolytics, beta
             blockers) must be on a stable dose for three weeks prior to initiation of randomized
             treatment.

          -  Significant personality dysfunction likely to interfere with study participation.

          -  Patients with a current or past history of seizures.

          -  Any concurrent psychotherapy initiated within 3 months of baseline, or ongoing
             psychotherapy of any duration directed specifically toward treatment of the SAD is
             excluded. Prohibited psychotherapy includes CBT or psychodynamic therapy focusing on
             exploring specific, dynamic causes of the phobic symptomatology and providing
             management skills. General supportive therapy initiated &gt; 3 months prior is
             acceptable.

          -  Prior non-response to adequately delivered exposure (i.e., as defined by the patient's
             report of receiving specific and regular exposure assignments as part of a previous
             treatment).

          -  Patients with a history of head trauma causing loss of consciousness, seizure or
             ongoing cognitive impairment.

          -  Subjects with back pain issues or medical conditions that would make it difficult to
             hold posture manipulations.

          -  Insufficient command of the English language.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Texas at Austin</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2015</study_first_submitted>
  <study_first_submitted_qc>June 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2015</study_first_posted>
  <results_first_submitted>May 10, 2017</results_first_submitted>
  <results_first_submitted_qc>October 6, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">October 16, 2017</results_first_posted>
  <last_update_submitted>October 19, 2017</last_update_submitted>
  <last_update_submitted_qc>October 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Phobia, Social</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Power Posing</title>
          <description>Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
        </group>
        <group group_id="P2">
          <title>Submissive Posing</title>
          <description>Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
        </group>
        <group group_id="P3">
          <title>Rest</title>
          <description>Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="23"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Power Posing</title>
          <description>Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
        </group>
        <group group_id="B2">
          <title>Submissive Posing</title>
          <description>Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
        </group>
        <group group_id="B3">
          <title>Rest</title>
          <description>Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="20"/>
            <count group_id="B4" value="73"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.88" spread="6.99"/>
                    <measurement group_id="B2" value="25.26" spread="8.99"/>
                    <measurement group_id="B3" value="24.60" spread="5.83"/>
                    <measurement group_id="B4" value="25.66" spread="7.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>LSAS-performance</title>
          <description>The Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.96" spread="14.39"/>
                    <measurement group_id="B2" value="36.19" spread="10.92"/>
                    <measurement group_id="B3" value="37.85" spread="10.16"/>
                    <measurement group_id="B4" value="37.27" spread="11.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Peak SUDS during exposure</title>
          <description>Peak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76.31" spread="14.86"/>
                    <measurement group_id="B2" value="77.74" spread="15.03"/>
                    <measurement group_id="B3" value="77.50" spread="11.20"/>
                    <measurement group_id="B4" value="77.16" spread="13.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>LSAS-performance Subscale</title>
        <description>Liebowitz Social Anxiety Scale (LSAS)-Performance Subscale at pre- and 1-week post-treatment.
The Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.</description>
        <time_frame>Scores at 1 week post-treatment</time_frame>
        <population>4 individuals did not complete LSAS at post-treatment; accordingly the analyses were conducted with only 69 individuals (versus the total sample size of 73) who had complete data.</population>
        <group_list>
          <group group_id="O1">
            <title>Power Posing</title>
            <description>Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
          </group>
          <group group_id="O2">
            <title>Submissive Posing</title>
            <description>Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
          </group>
          <group group_id="O3">
            <title>Rest</title>
            <description>Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
          </group>
        </group_list>
        <measure>
          <title>LSAS-performance Subscale</title>
          <description>Liebowitz Social Anxiety Scale (LSAS)-Performance Subscale at pre- and 1-week post-treatment.
The Liebowitz Social Anxiety Scale (LSAS) - Performance Subscale is a subscale of a common measure of social anxiety symptom severity. This subscale consists of only 13 (of the total 24) items related to performance situations. Participants rate both their fear (0 to 3) and avoidance (0 to 3) of these 13 situations, where higher scores indicate worse social anxiety severity. The minimum possible score on this subscale is 0 and the maximum possible score is 78.</description>
          <population>4 individuals did not complete LSAS at post-treatment; accordingly the analyses were conducted with only 69 individuals (versus the total sample size of 73) who had complete data.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="26"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.04" spread="14.76"/>
                    <measurement group_id="O2" value="32.54" spread="8.74"/>
                    <measurement group_id="O3" value="32.05" spread="13.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Units of Distress Scale (SUDs)</title>
        <description>Peak (max) SUDS ratings (0 to 100 scale) during treatment exposure and 1 week post-treatment exposure.
Peak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.</description>
        <time_frame>Scores at 1 week post-treatment</time_frame>
        <population>8 individuals did not complete the post-treatment exposure; accordingly the analyses were conducted with only 66 individuals (versus the total sample size of 73) who had complete data.</population>
        <group_list>
          <group group_id="O1">
            <title>Power Posing</title>
            <description>Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
          </group>
          <group group_id="O2">
            <title>Submissive Posing</title>
            <description>Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
          </group>
          <group group_id="O3">
            <title>Rest</title>
            <description>Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Units of Distress Scale (SUDs)</title>
          <description>Peak (max) SUDS ratings (0 to 100 scale) during treatment exposure and 1 week post-treatment exposure.
Peak Subjective Units of Distress Scale (SUDS) is the maximum amount of fear experienced rated on a 0 to 100 point scale, where 0 indicates no anxiety and 100 indicates the maximum level of anxiety.</description>
          <population>8 individuals did not complete the post-treatment exposure; accordingly the analyses were conducted with only 66 individuals (versus the total sample size of 73) who had complete data.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.26" spread="14.43"/>
                    <measurement group_id="O2" value="59.17" spread="23.85"/>
                    <measurement group_id="O3" value="48.75" spread="19.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Salivary Testosterone Levels</title>
        <description>Saliva sample taken before posture manipulation and 20 minutes after. Outcome is the change from pre- to post-manipulation in testosterone levels.</description>
        <time_frame>Baseline and 20 minutes after posture manipulation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Power Posing</title>
            <description>Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
          </group>
          <group group_id="O2">
            <title>Submissive Posing</title>
            <description>Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
          </group>
          <group group_id="O3">
            <title>Rest</title>
            <description>Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
          </group>
        </group_list>
        <measure>
          <title>Salivary Testosterone Levels</title>
          <description>Saliva sample taken before posture manipulation and 20 minutes after. Outcome is the change from pre- to post-manipulation in testosterone levels.</description>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.31" spread="10.82"/>
                    <measurement group_id="O2" value="-0.88" spread="33.31"/>
                    <measurement group_id="O3" value="-1.47" spread="54.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Power Posing</title>
          <description>Individuals hold two, 1-minute postures associated with dominance and high power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
        </group>
        <group group_id="E2">
          <title>Submissive Posing</title>
          <description>Individuals hold two, 1-minute postures associated with submissiveness and low power prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
        </group>
        <group group_id="E3">
          <title>Rest</title>
          <description>Individuals rest (no postures) for 2 minutes prior to exposure therapy.
Cognitive Behavioral Therapy: Exposure therapy for social anxiety disorder</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michelle Davis</name_or_title>
      <organization>University of Texas at Austin</organization>
      <phone>214-470-1371</phone>
      <email>michelledavis@utexas.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

